Inovio Pharmaceuticals Market Cap

Inovio Pharmaceuticals has a market cap or net worth of $93.00 million as of April 29, 2026. Its market cap has increased by 60.62% in one year.

Market Cap

93.00M

Enterprise Value

45.08M

1-Year Change

60.62%

Ranking

#4276

Market Cap Chart

Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $93.00M, an increase of 29.53%. That is a compound annual growth rate of 0.96%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	80.80M	-13.30%
Dec 31, 2025	93.20M	94.98%
Dec 31, 2024	47.80M	-65.66%
Dec 29, 2023	139.20M	-64.23%
Dec 30, 2022	389.20M	-62.93%
Dec 31, 2021	1.05B	-29.98%
Dec 31, 2020	1.50B	354.33%
Dec 31, 2019	330.00M	-13.48%
Dec 31, 2018	381.40M	2.28%
Dec 29, 2017	372.90M	-27.45%
Dec 30, 2016	514.00M	5.96%
Dec 31, 2015	485.10M	-12.78%
Dec 31, 2014	556.20M	-7.96%
Dec 31, 2013	604.30M	768.25%
Dec 31, 2012	69.60M	27.71%
Dec 30, 2011	54.50M	-54.51%
Dec 31, 2010	119.80M	2.92%
Dec 31, 2009	116.40M	408.30%
Dec 31, 2008	22.90M	-43.18%
Dec 31, 2007	40.30M	-65.53%
Dec 29, 2006	116.90M	163.88%
Dec 30, 2005	44.30M	-38.64%
Dec 31, 2004	72.20M	-1.77%
Dec 31, 2003	73.50M	440.44%
Dec 31, 2002	13.60M	-37.04%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Oncolytics Biotech	104.56M
Fractyl Health	104.12M
Anixa Biosciences	100.92M
Coya Therapeutics	99.93M
NRx Pharmaceuticals	97.45M
ProMIS Neurosciences	97.30M
Aldeyra Therapeutics	94.49M
NeurAxis	87.56M

Market Cap Rankings